KT-621 Significantly Downregulated Core Type 2 Inflammation
Gene Set in Skin Lesions of AD Patients
                                                                  p < 0.01            KT-621 (n=18)
                                                                                      Dupilumab2 (n=23)



• Genes in signature1:
   • CCL26/Eotaxin-3




                                            Signature Score
   • CCL17/TARC
   • CCL18/PARC
   • CCL13/MCP-4

• Changes in transcriptome comparable to
  published data for dupilumab at week 42



                                                              1                  29
                                                                    Time (Day)




                                                                                                   27
